WHO Drug Dictionary, IDMP & Product Identification · Section 16.7
~3 min read · The Drug Safety Coach — Global PV Career Course
Key points
Full text
This module completed the identification discipline Module 4 began — where that module built how the event side of a case gets coded and standardised, this one built how the product side gets identified: the WHO Drug Dictionary’s name-linking approach, the five ISO IDMP standards’ more structurally rigorous framework, and the EU’s concrete XEVMPD/SPOR implementation of it in practice.
The throughline connecting this module back to the rest of the course was the same principle Module 4 established and this module mirrored precisely: signal detection, the core discipline Module 7 built, is only as reliable as the identification quality on BOTH sides of every case record. A perfectly coded event attached to a poorly, inconsistently identified product is exactly as useless to a disproportionality analysis as a well-identified product paired with sloppy event coding — both fail for the identical underlying reason, related cases not being recognisable as related.
Key references: WHO Collaborating Centre for Drug Statistics Methodology (WHO-DD, ATC classification), ISO 11615/11616/11238/11239/11240 (IDMP standards), EMA XEVMPD/EVWEB training documentation, EMA SPOR programme documentation, DIA IDMP webinar series.
Key Concept
"MedDRA answers ‘what happened.’ IDMP and WHO-DD answer ‘to which exact product.’ Neither question means anything on its own — a perfectly coded event attached to an ambiguous, poorly-identified product is just as useless to signal detection as a perfectly identified product with sloppy event coding. This module completed the other half of the identification discipline this course has been building since Module 4." — Vinay Kumar
Quick check
Test yourself before moving on — no pressure, just click an answer.
1. What is the central parallel this module draws between product identification and Module 4’s MedDRA coding content?